Calculation
| Debt to equity | = | Total debt1 | ÷ | Stockholders’ equity1 | |
|---|---|---|---|---|---|
| Dec 31, 2022 | 0.51 | = | 8,935) | ÷ | 17,573) |
| Dec 31, 2021 | 0.55 | = | 9,065) | ÷ | 16,622) |
| Dec 31, 2020 | 0.60 | = | 9,143) | ÷ | 15,326) |
| Dec 31, 2019 | 0.72 | = | 10,008) | ÷ | 13,877) |
| Dec 31, 2018 | 0.81 | = | 7,056) | ÷ | 8,726) |
| Dec 31, 2017 | 0.80 | = | 5,616) | ÷ | 7,012) |
| Dec 31, 2016 | 0.81 | = | 5,484) | ÷ | 6,733) |
| Dec 31, 2015 | 0.90 | = | 5,677) | ÷ | 6,320) |
| Dec 31, 2014 | 0.66 | = | 4,262) | ÷ | 6,457) |
| Dec 31, 2013 | 0.65 | = | 4,240) | ÷ | 6,539) |
| Dec 31, 2012 | 0.62 | = | 4,256) | ÷ | 6,870) |
| Dec 31, 2011 | 0.38 | = | 4,261) | ÷ | 11,353) |
| Dec 31, 2010 | 0.48 | = | 5,438) | ÷ | 11,296) |
| Dec 31, 2009 | 0.48 | = | 5,918) | ÷ | 12,301) |
| Dec 31, 2008 | 0.51 | = | 6,745) | ÷ | 13,174) |
| Dec 31, 2007 | 0.54 | = | 8,189) | ÷ | 15,097) |
| Dec 31, 2006 | 0.60 | = | 9,124) | ÷ | 15,298) |
| Dec 31, 2005 | 0.47 | = | 2,020) | ÷ | 4,282) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
The financial data indicates a dynamic shift in capital structure between 2005 and 2022, characterized by distinct cycles of leverage expansion and equity growth.
- Total Debt Trends
- A significant escalation in total debt occurred between 2005 and 2006, rising from $2.02 billion to $9.12 billion. This was followed by a sustained period of deleveraging from 2007 through 2014, where debt levels declined to a low of $4.24 billion. A subsequent increase in borrowing was observed from 2015 to 2019, with total debt peaking at $10.01 billion before experiencing a slight decline to $8.94 billion by 2022.
- Stockholders' Equity Evolution
- Equity levels increased sharply in 2006 to $15.30 billion, followed by a decade of gradual erosion, reaching a minimum of $6.32 billion in 2014. Starting in 2015, a strong and consistent recovery phase began, with equity growing annually to reach a period high of $17.57 billion by the end of 2022.
- Debt to Equity Ratio Analysis
- The leverage ratio remained relatively stable and low between 2005 and 2011, fluctuating between 0.38 and 0.60. A period of increasing leverage began in 2012, culminating in a peak ratio of 0.90 in 2015. Since 2015, the ratio has followed a consistent downward trajectory, ending at 0.51 in 2022, reflecting a strategic shift toward a more equity-heavy capital structure and reduced relative indebtedness.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Comparison to Competitors
| Boston Scientific Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2022 | 0.51 | 0.46 | 0.66 | 0.00 | 0.46 | 0.74 |
| Dec 31, 2021 | 0.55 | 0.50 | 0.64 | 0.00 | 0.51 | 0.64 |
| Dec 31, 2020 | 0.60 | 0.57 | 0.60 | 0.00 | 0.49 | 0.66 |
| Dec 31, 2019 | 0.72 | 0.58 | 0.63 | 0.00 | 0.51 | 0.71 |
| Dec 31, 2018 | 0.81 | 0.64 | 0.67 | 0.00 | 0.51 | 0.71 |
| Dec 31, 2017 | 0.80 | 0.90 | 0.75 | 0.00 | 0.66 | 0.66 |
| Dec 31, 2016 | 0.81 | 1.07 | 0.63 | 0.00 | 0.60 | 0.86 |
| Dec 31, 2015 | 0.90 | 0.42 | 0.69 | 0.00 | 0.68 | 0.95 |
| Dec 31, 2014 | 0.66 | 0.36 | 0.62 | 0.00 | 0.61 | 0.54 |
| Dec 31, 2013 | 0.65 | 0.26 | 0.59 | 0.00 | 0.57 | 0.52 |
| Dec 31, 2012 | 0.62 | 0.77 | 0.63 | 0.00 | 0.62 | 0.54 |
| Dec 31, 2011 | 0.38 | 0.63 | 0.42 | 0.00 | 0.62 | 0.41 |
| Dec 31, 2010 | 0.48 | 0.85 | 0.38 | 0.00 | 0.65 | 0.43 |
| Dec 31, 2009 | 0.48 | 0.72 | 0.34 | 0.00 | 0.57 | 0.47 |
| Dec 31, 2008 | 0.51 | 0.65 | 0.41 | 0.00 | 0.60 | 0.62 |
| Dec 31, 2007 | 0.54 | 0.69 | 0.39 | 0.00 | 0.55 | 0.55 |
| Dec 31, 2006 | 0.60 | 0.88 | 0.29 | 0.00 | 0.84 | 0.36 |
| Dec 31, 2005 | 0.47 | 0.46 | 0.27 | 0.00 | 0.23 | 0.40 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Boston Scientific Corp., debt to equity, long-term trends, comparison to sector (health care equipment & services)
| Boston Scientific Corp. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2022 | 0.51 | 0.57 |
| Dec 31, 2021 | 0.55 | 0.55 |
| Dec 31, 2020 | 0.60 | 0.56 |
| Dec 31, 2019 | 0.72 | 0.58 |
| Dec 31, 2018 | 0.81 | 0.60 |
| Dec 31, 2017 | 0.80 | 0.71 |
| Dec 31, 2016 | 0.81 | 0.72 |
| Dec 31, 2015 | 0.90 | 0.69 |
| Dec 31, 2014 | 0.66 | 0.52 |
| Dec 31, 2013 | 0.65 | 0.47 |
| Dec 31, 2012 | 0.62 | 0.61 |
| Dec 31, 2011 | 0.38 | 0.49 |
| Dec 31, 2010 | 0.48 | 0.55 |
| Dec 31, 2009 | 0.48 | 0.51 |
| Dec 31, 2008 | 0.51 | 0.55 |
| Dec 31, 2007 | 0.54 | 0.53 |
| Dec 31, 2006 | 0.60 | 0.50 |
| Dec 31, 2005 | 0.47 | 0.34 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
| Boston Scientific Corp. | Health Care | |
|---|---|---|
| Dec 31, 2022 | 0.51 | 0.72 |
| Dec 31, 2021 | 0.55 | 0.80 |
| Dec 31, 2020 | 0.60 | 0.92 |
| Dec 31, 2019 | 0.72 | 0.90 |
| Dec 31, 2018 | 0.81 | 0.80 |
| Dec 31, 2017 | 0.80 | 0.82 |
| Dec 31, 2016 | 0.81 | 0.77 |
| Dec 31, 2015 | 0.90 | 0.69 |
| Dec 31, 2014 | 0.66 | 0.54 |
| Dec 31, 2013 | 0.65 | 0.50 |
| Dec 31, 2012 | 0.62 | 0.54 |
| Dec 31, 2011 | 0.38 | 0.47 |
| Dec 31, 2010 | 0.48 | 0.43 |
| Dec 31, 2009 | 0.48 | 0.42 |
| Dec 31, 2008 | 0.51 | 0.42 |
| Dec 31, 2007 | 0.54 | 0.36 |
| Dec 31, 2006 | 0.60 | 0.32 |
| Dec 31, 2005 | 0.47 | 0.30 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).